TY1 and Semaglutide to Treat Cardiometabolic HFpEF Post author: Post published:June 29, 2026 Post category: Continue ReadingTY1 and Semaglutide to Treat Cardiometabolic HFpEF
CRISPR/Cas9-mediated gene editing of Hematopoietic stem and progenitor cells for Friedreich’s ataxia Post author: Post published:June 29, 2026 Post category: Continue ReadingCRISPR/Cas9-mediated gene editing of Hematopoietic stem and progenitor cells for Friedreich’s ataxia
Noncoding RNA drug TY2 for arrhythmogenic cardiomyopathy Post author: Post published:June 29, 2026 Post category: Continue ReadingNoncoding RNA drug TY2 for arrhythmogenic cardiomyopathy
Development of an AAV Epigenetic Gene Therapy for Intractable Chronic Pain Disorders Post author: Post published:June 29, 2026 Post category: Continue ReadingDevelopment of an AAV Epigenetic Gene Therapy for Intractable Chronic Pain Disorders
Stem Cell-Based Cartilage Tissue Regeneration Post author: Post published:June 29, 2026 Post category: Continue ReadingStem Cell-Based Cartilage Tissue Regeneration
Autologous iPSC-derived progenitor smooth muscle cells for treatment of urinary incontinence Post author: Post published:June 29, 2026 Post category: Continue ReadingAutologous iPSC-derived progenitor smooth muscle cells for treatment of urinary incontinence
